Page last updated: 2024-08-24

n-acetylaspartic acid and Disease Exacerbation

n-acetylaspartic acid has been researched along with Disease Exacerbation in 142 studies

Research

Studies (142)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (7.75)18.2507
2000's74 (52.11)29.6817
2010's54 (38.03)24.3611
2020's3 (2.11)2.80

Authors

AuthorsStudies
Blicher, JU; Eskildsen, SF; Figlewski, K; Møller, AT; Near, J; Stærmose, TG1
Andres-Mach, M; Chudzik, A; Kochalska, K; Kozioł, P; Oakden, W; Orzylowska, A; Pankowska, A; Pietura, R; Rola, R; Stanisz, GJ; Słowik, T; Łazorczyk, A1
Barkhof, F; Chataway, J; DeAngelis, F; Doshi, A; Gandini Wheeler-Kingshott, CAM; John, NA; MacManus, D; Marshall, I; Monteverdi, A; Parker, RA; Plantone, D; Prados, F; Schneider, T; Solanky, BS; Stutters, J; Weir, CJ1
Briemberg, H; Eurich, DT; Frayne, R; Genge, AL; Graham, SJ; Hanstock, C; Ishaque, A; Kalra, S; Korngut, L; Luk, C; Seres, P; Srivastava, O; Ta, D; Zinman, L1
Babb, JS; Davitz, MS; Gonen, O; Herbert, J; Kirov, II; Liu, S; Rusinek, H; Tal, A; Wu, WE1
Angelini, C; Giacanelli, M; Gurrieri, F; Lispi, L; Luna, R; Neri, G; Petrucci, A1
Moriya, M; Nojo, T; Waragai, M1
Bushara, KO; Deelchand, DK; Eberly, LE; Emir, UE; Gomez, CM; Hutter, D; Joers, JM; Lyu, T; Öz, G1
Grendar, M; Hnilicova, P; Kantorova, E; Kurca, E; Polacek, H; Zelenak, K1
Gonzales, SS; Kraguljac, NV; Lahti, AC; Morgan, CJ; Sivaraman, S; White, DM1
Cheong, I; Deelchand, DK; Eberly, LE; Guliani, G; Manousakis, G; Marjańska, M; Öz, G; Walk, D1
Andersen, CU; Brock, B; Brock, C; Drewes, AM; Frøkjær, JB; Hansen, TM; Jakobsen, PE; Juhl, A; Karmisholt, J; Vorum, H1
Kantarci, K1
Algers, J; Brown, M; Buchthal, S; Campbell, T; Cohen, RA; Daar, E; Gongvatana, A; Harezlak, J; Heaton, R; McMahon, D; Mi, D; Navia, B; Robertson, K; Schifitto, G; Singer, E; So, YT; Taylor, M; Yiannoutsos, C; Zhong, J1
Amato, MP; Bartolozzi, ML; Battaglini, M; De Stefano, N; Gasperini, C; Giorgio, A; Hakiki, B; Malentacchi, G; Portaccio, E; Rossi, F; Santangelo, M; Stromillo, ML1
Bellenberg, B; Busch, M; Chan, A; Gold, R; Lukas, C; Trampe, N1
Abe, O; Aoki, Y; Gonoi, W; Inoue, H; Iwashiro, N; Kasai, K; Katsura, M; Koike, S; Natsubori, T; Sasaki, H; Takano, Y; Takao, H; Yahata, N; Yamasue, H1
Cao, Z; Chen, Y; Dai, H; Li, H; Lin, Y; Pang, L; Wu, R; Yao, J; You, K1
Blinkenberg, M; Hanson, LG; Mathiesen, HK; Paulson, OB; Skimminge, A; Sorensen, PS; Wu, X1
Arai, H; Fujii, C; Hata, S; Higuchi, S; Igarashi, K; Ishii, R; Iwai, N; Moriya, M; Ohrui, T; Suzuki, T; Tokuda, T; Uemura, K; Waragai, M; Yoshida, M1
Brenneman, D; Cree, BA; Hauser, SL; Kornak, J; Llufriu, S; Nelson, SJ; Oh, J; Pelletier, D; Ratiney, H; Sampat, M1
Anderson, CM; Bayouth, JE; Buatti, JM; Capizzano, AA; Clerkin, PP; Magnotta, V; McGuire, SM; Morris, A; Muruganandham, M; Smith, BJ; Smith, MC1
Bellini, T; Blankenstein, MA; Comabella, M; Killestein, J; Koel-Simmelink, MJ; Korth, C; Montalban, X; Ottis, P; Roos, B; Rovira, A; Teunissen, CE; Tintoré, M; Trentini, A1
Fan, Y; Zhou, L1
Akiguchi, I; Shiino, A; Watanabe, T1
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL1
Adams, D; Baker, EH; Golas, G; Johnston, J; Kwon, HJ; Latour, Y; Portner, C; Regier, DS; Thomas, S; Tifft, CJ; Vezina, G; Wiggs, E; Yang, S1
Aleman, A; Bais, L; de Vos, A; Dlabac-De Lange, J; Knegtering, H; Liemburg, E; Opmeer, E; Pijnenborg, G; Sibeijn-Kuiper, A; van der Velde, J; Wunderink, L1
Audoin, B; Burzykowski, T; Chabrol, B; Galanaud, D; Kaphan, E; Sedel, F; Tourbah, A; Tranchant, C; Vanier, MT1
Broniscer, A; Edwards, A; Hwang, S; Li, X; Li, Y; Löbel, U; Patay, Z1
Botzkowski, D; Gass, A; Kuhle, J; Müller, S; Pardini, M; Putzki, N; Ruberte, E; Tettenborn, B; Valmaggia, C; Vehoff, J; Würfel, J; Yaldizli, Ö1
Morton, AJ; Sawiak, SJ; Wood, NI1
Bilaniuk, LT; De Vivo, DC; Francis, JS; Gray, SJ; Janson, CG; Leone, P; Markov, V; McCown, TJ; Samulski, RJ; Wang, DJ; Wojtas, I1
Boonzaier, NR; Larkin, TJ; Matys, T; Price, SJ; van der Hoorn, A; Yan, JL1
Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG1
Barres, BA; Cerda, SR; Dugas, J; Popko, B; Traka, M; Wollmann, RL1
Baik, SK; Chang, KH; Cho, BM; Choi, SH; Kim, DH; Kim, HJ; Kim, YW; Lee, JW; Lee, SH1
Armitage, PA; Bastin, ME; Chappell, FM; Cvoro, V; Marshall, I; Muñoz Maniega, S; Wardlaw, JM1
Cooper, A; Daly, E; Foy, C; Glover, A; Hye, A; Lovestone, S; Murphy, D; Simmons, A; Thambisetty, M1
Aresi, A; Bizzi, A; Giovagnoli, AR; Gobbo, C; Reati, F; Riva, A1
Beaulieu, C; Concha, L; Hanstock, C; Hui, B; Johnston, W; Kalra, S; Pyra, T; Wong, JC1
Imamura, A; Ito, R; Miyajima, H; Orii, KO1
Blom, HJ; Bouwman, F; Brundin, L; Dijkstra, CD; Iacobaeus, E; Jakobs, C; Khademi, M; Koel-Simmelink, MJ; Norgren, N; Schepens, M; Teunissen, CE; Twaalfhoven, HA1
Bazner, S; González, RG; Halpern, EF; Kim, WK; Lee, V; Lentz, MR; Rosenberg, ES; Venna, N; Williams, K1
Boeve, BF; Jack, CR; Kantarci, K; Knopman, DS; Negash, S; O'Brien, PC; Petersen, RC; Przybelski, SA; Shiung, MM; Weigand, SD; Whitwell, JL1
Frölich, L; Kratzsch, T; Lais, C; Lanfermann, H; Maurer, K; Pantel, J; Pilatus, U; Rochmont, Adu M; Zanella, FE1
Benedetti, B; Bertolotto, A; Capra, R; Caputo, D; Comi, G; Filippi, M; Martinelli, V; Rocca, MA; Rovaris, M; Zaffaroni, M1
Erdinc, O; Gumustas, OG; Kabay, SC; Karaman, HO; Ozden, H1
Gibikote, S; Kumar, S; Moses, PD; Puliyel, MM; Rose, W1
Crawford, EL; Hsu, O; Mayer, D; Pfefferbaum, A; Rohlfing, T; Sullivan, EV; Vinco, S; Zahr, NM1
Fink, JR; Maravilla, KR; Matsusue, E; Ogawa, T; Rockhill, JK1
Herrera, JJ; Narayana, PA; Qian, J1
Bianchi, F; Bongioanni, P; Canapicchi, R; Frijia, F; Hlavata, H; Lombardo, F; Minichilli, F; Montanaro, D; Rossi, B1
Altmann, DR; Ciccarelli, O; McLean, MA; Miller, DH; Thompson, AJ; Wheeler-Kingshott, CA; Wimpey, K1
Geurts, JJ; van Horssen, J1
de Diego-Adeliño, J; Gómez-Ansón, B; Morgan-Ferrando, R; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D; Ruscalleda, J; Vives, Y1
Davies, NP; Davison, JE; Gissen, P; Hendriksz, CJ; Peet, AC; Sun, Y1
Barton, NW; Fogh, J; Hanson, LG; i Dali, C; Lund, AM; Nair, N1
Audoin, B; Confort-Gouny, S; Cozzone, PJ; Crespy, L; Faivre, A; Le Fur, Y; Malikova, I; Pelletier, J; Ranjeva, JP; Reuter, F; Rico, A; Soulier, E; Viout, P; Zaaraoui, W1
Brugger, S; Davis, JM; Leucht, S; Stone, JM1
Chang, Y; Choi, BS; Jung, C; Kim, JH; Kim, S1
Fujita, K; Harada, M; Izumi, Y; Kaji, R; Sasaki, M; Yuasa, T1
Barcikowska, M; Ćwikła, JB; Gabryelewicz, T; Walecki, J1
Larner, J; Lopes, MB; Nicolasjilwan, M; Schiff, D; Wintermark, M1
Choi, IY; Lee, P; Smirnova, IV; Wang, WT; Yeh, HW1
Choi, JY; Hong, YH; Kim, HS; Lee, HY; Lim, TS; Moon, SY1
Alkan, A; Dogan, DG; Dogan, M; Kahraman, AS; Ozcan, O; Yakinci, C1
Malik, R; Smith, J; Viola, RE; Wijayasinghe, YS; Zano, S1
Chen, HC; Lirng, JF; Soong, BW; Wang, PS; Wu, HM; Wu, YT1
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J1
Angebault, C; Bielicki, G; Boddaert, N; Brabet, P; Cazevieille, C; Chaix, B; Delettre, C; Gueguen, N; Hamel, CP; Lenaers, G; Mausset-Bonnefont, AL; Puel, JL; Renou, JP; Reynier, P; Rigau, V; Sarzi, E; Seveno, M; Wang, J1
Ariaudo, G; Balottin, U; Bastianello, S; Orcesi, S; Pichiecchio, A; Tonduti, D; van der Knaap, MS; Wolf, NI1
Alberti, A; Chiarini, P; Gallai, V; Gobbi, G; Pelliccioli, GP; Presciutti, O; Sarchielli, P; Tarducci, R1
Bozzali, M; Comi, G; Falini, A; Filippi, M; Ghezzi, A; Gonen, O; Grossman, RI; Kesavadas, C; Martinelli, V; Rovaris, M; Scotti, G1
Arnold, D; Blamire, AM; Corkill, R; Matthews, PM; Narayanan, S; Palace, J; Parry, A; Styles, P1
Hadjiconstantinou, M; Neff, NH; Podell, M; Smith, MA1
Brockmann, K; Dechent, P; Frahm, J; Hanefeld, F; Haupt, M; Meins, M; Sperner, J; Stephani, U1
Butman, JA; Floeter, MK; Pagan, F; Statland, J; Zhai, P1
Confort-Gouny, S; Cozzone, PJ; Denis, B; Lefur, Y; Nicoli, F; Ranjeva, JP1
Glosser, G; Gonen, O; Grossman, RI; Inglese, M; Kolson, DL; Patel, SH1
Sener, RN1
Chen, CY; Chin, SC; Chung, HW; Huang, IJ; Lee, CS; Liou, M; Liu, YJ1
Mazurek, AA1
Babb, JS; Ge, Y; Gonen, O; Grossman, RI; Inglese, M; Markowitz, CE1
Astrakas, LG; Black, PM; Goumnerova, L; Poussaint, TY; Tarbell, NJ; Tzika, AA; Zarifi, MK; Zurakowski, D1
Fuller, RA; González, RG; Greco, JB; Halpern, E; He, J; Kim, JP; Lackner, AA; Lentz, MR; Masliah, E; Ratai, E; Sehgal, PK; Westmoreland, SV1
Barker, PB; Bibat, G; Costa Leite, C; Costa, MO; Fatemi, A; Horská, A; Kok, F; Lacerda, MT; Nagae-Poetscher, LM; Naidu, S; Philippart, M; Rosemberg, S1
Gabreëls, FJ; Heerschap, A; Rotteveel, JJ; Van Der Graaf, M; Van Der Knaap, MS; Van Domburg, PH; Willemsen, MA1
Alkan, A; Aslan, M; Kutlu, R; Sarac, K; Sigirci, A; Yakinci, C1
Beley, A; Demougeot, C; Giroud, M; Marie, C1
Aärimaa, T; Autti, T; Häkkinen, AM; Koillinen, H; Kuusi, T; Linnankivi, T; Lönnqvist, T; Lundbom, N; Pihko, H; Sainio, K; Valanne, L1
Chan, AA; Chang, SM; Dillon, WP; Larson, D; Lau, A; McDermott, MW; Nelson, SJ; Pirzkall, A; Verhey, LJ1
Du Pasquier, RA; Katz-Brull, R; Koralnik, IJ; Lenkinski, RE1
Jacobsen, H; Künnecke, B; Loetscher, H; Metzger, F; Ozmen, L; Richards, JG; Steiner, G; von Kienlin, M1
Ashwal, S; Gross, M; Holshouser, B; Kido, D; Osterdock, R; Serna, T; Tong, K1
Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL1
Bjoraker, KJ; Charnas, LR; Choi, IY; Gruetter, R; Oz, G; Shapiro, EG; Tkác, I1
Antel, JP; Arnold, DL; Biernacki, K; Blain, M; Narayanan, S; Prat, A1
Chard, DT; Ingle, GT; McLean, MA; Miller, DH; Ramió-Torrentà, L; Sastre-Garriga, J; Thompson, AJ1
Banerjee, A; Cha, S; Haas-Kogan, DA; Laprie, A; Le, TP; Lu, Y; McKnight, TR; Nelson, S; Pirzkall, A1
Cherubini, A; Feliziani, FT; Gobbi, G; Mariani, E; Mecocci, P; Metastasio, A; Pelliccioli, GP; Rinaldi, P; Senin, U; Tarducci, R1
Battaglini, M; Borsini, W; Bramanti, P; Buchner, S; De Stefano, N; Federico, A; Giorgio, A; Marino, S; Mortilla, M; Stromillo, ML1
Asano, T; Kato, Z; Kondo, N1
Bachert, P; Debus, J; Hamprecht, F; Kauczor, HU; Lichy, MP; Schlemmer, HP; Schulz-Ertner, D; Weber, MA1
Boeve, BF; Gunter, J; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; O'Brien, PC; Petersen, RC; Reyes, D; Shiung, M; Smith, GE; Tangalos, EG; Weigand, SD1
Appenzeller, S; Cendes, F; Costallat, LT; Li, LM1
Angenstein, F; Debska-Vielhaber, G; Heinze, HJ; Hilfert, L; Kunz, WS; Leibfritz, D; Ludolph, AC; Niessen, HG; Sander, K; Vielhaber, S; Willker, W1
Anlar, B1
Anthony, DC; Blamire, AM; Broom, KA; Griffin, JL; Lowe, JP; Perry, VH; Scott, H; Sibson, NR; Styles, P1
Barrios, L; Cerdán, S; López-Larrubia, P; Pascual, JM; Prieto, R; Roda, JM; Solivera, J1
Boscá, I; Casanova, B; Celda, B; Coret, F; Marti-Bonmati, L; Martínez-Bisbal, MC; Martínez-Granados, B; Mir, A; Pascual, AM; Valero, C1
Ballon, D; Crystal, RG; Dyke, JP; Hackett, NR; Heier, L; Hollmann, C; Kaplitt, MG; Kekatpure, MV; Kosofsky, B; Mao, X; Shungu, D; Sondhi, D; Souweidane, MM; Worgall, S1
Alimenti, A; de Tribolet, N; Delavelle, J; Dietrich, PY; Lazeyras, F; Lövblad, KO; Yilmaz, H1
Azevedo, D; Bazzarella, MC; Bottino, CM; Castro, CC; Hototian, SR; Tatsch, M1
Casey, PA; Fiskum, G; McKenna, MC; Robertson, CL; Saraswati, M1
Andermann, F; Arnold, DL; Cendes, F; Silver, K1
Arnold, DL; Collins, DL; De Stefano, N; Fu, L; Narayanan, S; Wolfson, C; Worsley, KJ1
Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G1
Chang, S; Day, MR; Dillon, WP; Gutin, PH; Henry, RG; Huhn, SL; Larson, DA; McDermott, M; Nelson, SJ; Noworolski, SE; Prados, MD; Sneed, PK; Vigneron, DB; Wald, LL; Wara, WM1
Calabrese, G; Colombo, B; Comi, G; Falini, A; Filippi, M; Lipari, S; Origgi, D; Scotti, G1
Christen, HJ; Frahm, J; Hanefeld, FA; Kruse, B; Pouwels, PJ1
Antel, JP; Arnold, DL; De Stefano, N; Francis, GS; Fu, L; Matthews, PM; Narayanan, S; Stanley, J1
Charles, HC; Doraiswamy, PM; Krishnan, KR1
Abe, K; Fujita, N; Hirabuki, N; Nakamura, M; Terakawa, H; Watanabe, Y; Yanagihara, T1
Arnold, DL; Cashman, NR; Kalra, S1
de Mari, M; Federico, F; Ferrari, E; Lamberti, P; Lucivero, V; Mezzapesa, DM; Petruzzellis, M; Simone, IL1
Babb, JS; Catalaa, I; Ge, Y; Gonen, O; Grossman, RI; Kolson, DL; Mannon, LJ1
Bendszus, M; Burger, R; Klein, R; Schichor, C; Solymosi, L; Tonn, JC; Warmuth-Metz, M1
Alonso, J; Cucurella, MG; Montalbán, X; Pedraza, S; Río, J; Rovira, A; Tintoré, MM1
Adalsteinsson, E; Kleinhans, N; Pfefferbaum, A; Spielman, DM; Sullivan, EV1
Boeve, BF; Campeau, NG; Ivnik, RJ; Jack, CR; Kantarci, K; Kokmen, E; O'Brien, PC; Petersen, RC; Smith, GE; Tangalos, EG; Xu, YC1
Goto, H; Hoshi, H; Kato, Z; Kondo, N; Mizuno, S; Takahashi, Y1
Antel, JP; Arnaoutelis, R; Arnold, DL; De Stefano, N; Francis, GS; Matthews, PM; Narayanan, S; Tartaglia, MC1
Arnold, DL; Bartolozzi, ML; De Stefano, N; Federico, A; Guidi, L; Mortilla, M; Narayanan, S1
Block, W; Grothe, C; Karitzky, J; Klockgether, T; Lamerichs, R; Pohl, C; Schild, H; Schmidt, S; Träber, F1
Arnold, DL; De Stefano, N; Matthews, PM; Narayanan, S1
Arnold, DL; Matthews, PM1
Malloy, CR1
Balestri, P; De Stefano, N; Dotti, MT; Federico, A; Grosso, S; Morgese, G; Mortilla, M1
Kobayashi, M; Mihara, B; Suga, S; Takayama, H1
Matthews, PM1
Dronsky, V; Gelinas, D; Licht, J; Maudsley, AA; Miller, RG; Rule, R; Schuff, N; Suhy, J; Weiner, MW1

Reviews

8 review(s) available for n-acetylaspartic acid and Disease Exacerbation

ArticleYear
Proton MRS in mild cognitive impairment.
    Journal of magnetic resonance imaging : JMRI, 2013, Volume: 37, Issue:4

    Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Diagnosis, Differential; Disease Models, Animal; Disease Progression; Energy Metabolism; Humans; Inositol; Magnetic Resonance Spectroscopy; Mice; Translational Research, Biomedical

2013
Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.
    Biological psychiatry, 2011, Mar-01, Volume: 69, Issue:5

    Topics: Aspartic Acid; Data Interpretation, Statistical; Disease Progression; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Publication Bias; Regression Analysis; Risk; Schizophrenia; Schizophrenic Psychology; Temporal Lobe; Thalamus

2011
N-acetylaspartate: a literature review of animal research on brain ischaemia.
    Journal of neurochemistry, 2004, Volume: 90, Issue:4

    Topics: Animals; Aspartic Acid; Brain Ischemia; Chromatography, High Pressure Liquid; Disease Models, Animal; Disease Progression; Magnetic Resonance Spectroscopy; Neurons

2004
Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of systemic lupus erythematosus.
    Arthritis and rheumatism, 2006, Oct-15, Volume: 55, Issue:5

    Topics: Aspartic Acid; Brain; Central Nervous System; Creatine; Disease Progression; Humans; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Spectroscopy; Neurons

2006
Biological markers in the diagnosis and treatment of ALS.
    Journal of the neurological sciences, 1999, Volume: 165 Suppl 1

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Progression; Electromyography; Humans; Magnetic Resonance Imaging; Monitoring, Physiologic; Neuroprotective Agents; Riluzole; Tomography, Emission-Computed

1999
Imaging axonal damage in multiple sclerosis by means of MR spectroscopy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000, Volume: 21, Issue:4 Suppl 2

    Topics: Animals; Aspartic Acid; Axons; Central Nervous System; Disability Evaluation; Disease Progression; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis

2000
Proton MR spectroscopy in multiple sclerosis.
    Neuroimaging clinics of North America, 2000, Volume: 10, Issue:4

    Topics: Aspartic Acid; Brain; Choline; Creatine; Disability Evaluation; Disease Progression; Energy Metabolism; Humans; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Retrograde Degeneration

2000
Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution.
    Current opinion in neurology, 2001, Volume: 14, Issue:3

    Topics: Aspartic Acid; Axons; Brain; Disability Evaluation; Disease Progression; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Neurologic Examination

2001

Trials

11 trial(s) available for n-acetylaspartic acid and Disease Exacerbation

ArticleYear
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
    AJNR. American journal of neuroradiology, 2020, Volume: 41, Issue:12

    Topics: Adult; Amiloride; Aspartic Acid; Biomarkers; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Fluoxetine; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neuroimaging; Neuroprotective Agents; Proton Magnetic Resonance Spectroscopy; Protons; Riluzole

2020
1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis.
    European radiology, 2013, Volume: 23, Issue:12

    Topics: Adult; Analysis of Variance; Aspartic Acid; Cervical Vertebrae; Creatine; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Spinal Cord; Young Adult

2013
Randomized trial of erhuangfang for relapsing multiple sclerosis.
    Neurological research, 2015, Volume: 37, Issue:7

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Aspartic Acid; Brain; Creatine; Disability Evaluation; Disease Progression; Drugs, Chinese Herbal; Female; Humans; Magnetic Resonance Spectroscopy; Male; Medicine, Chinese Traditional; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Young Adult

2015
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease Progression; Female; Glioma; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Tamoxifen

2008
Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
    Archives italiennes de biologie, 2009, Volume: 147, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Choline; Creatinine; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Disease Progression; Female; Humans; Male; Middle Aged; Phosphocreatine; Pyramidal Tracts; Reproducibility of Results; Sensitivity and Specificity

2009
Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
    Neurology, 2010, Nov-23, Volume: 75, Issue:21

    Topics: Aspartic Acid; Biomarkers; Brain; Child, Preschool; Choline; Cognition; Creatine; Disease Progression; Female; Humans; Leukodystrophy, Metachromatic; Magnetic Resonance Spectroscopy; Male; Movement; Sensitivity and Specificity

2010
Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Journal of neurology, 2003, Volume: 250, Issue:2

    Topics: Adult; Aspartic Acid; Axons; Body Water; Brain Chemistry; Cohort Studies; Creatine; Disease Progression; Female; Humans; Interferon Type I; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Recombinant Proteins; Recurrence

2003
Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study.
    Stroke, 2003, Volume: 34, Issue:7

    Topics: Acute Disease; Adult; Aged; Aspartic Acid; Brain; Brain Ischemia; Cerebrovascular Circulation; Diffusion; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Gadolinium; Humans; Lactic Acid; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Protons; Stroke; Time Factors

2003
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Archives of neurology, 2005, Volume: 62, Issue:4

    Topics: Adult; Age of Onset; Aged; Aspartic Acid; Biomarkers; Case-Control Studies; Cerebral Cortex; Choline; Disability Evaluation; Disease Progression; Female; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Fibers, Myelinated; Neurons; Neuropil; Phosphocreatine; Predictive Value of Tests; Reference Values; Statistics as Topic

2005
Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Atrophy; Brain; Choline; Cognition Disorders; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Protons; Residence Characteristics

2008
Longitudinal changes of metabolites in frontal lobes after hemorrhagic stroke of basal ganglia: a proton magnetic resonance spectroscopy study.
    Stroke, 2001, Volume: 32, Issue:10

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Basal Ganglia Hemorrhage; Creatine; Disease Progression; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Stroke; Treatment Outcome

2001

Other Studies

123 other study(ies) available for n-acetylaspartic acid and Disease Exacerbation

ArticleYear
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
    Scientific reports, 2019, 11-26, Volume: 9, Issue:1

    Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Gray Matter; Hand Strength; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Occipital Lobe; Pilot Projects; Severity of Illness Index; Single-Blind Method

2019
Dietary supplementation with Lactobacillus rhamnosus JB-1 restores brain neurochemical balance and mitigates the progression of mood disorder in a rat model of chronic unpredictable mild stress.
    Nutrition research (New York, N.Y.), 2020, Volume: 82

    Topics: Animals; Aspartic Acid; Behavior, Animal; Brain; Choline; Depressive Disorder; Dietary Supplements; Disease Progression; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Lacticaseibacillus rhamnosus; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Stress, Psychological

2020
Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
    Neurology, 2021, 08-24, Volume: 97, Issue:8

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Prefrontal Cortex; Severity of Illness Index

2021
Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Human brain mapping, 2017, Volume: 38, Issue:8

    Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Organ Size; Proton Magnetic Resonance Spectroscopy; White Matter; Young Adult

2017
ATP1A3 mutant patient with alternating hemiplegia of childhood and brain spectroscopic abnormalities.
    Journal of the neurological sciences, 2017, 08-15, Volume: 379

    Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Choline; Disease Progression; Hemiplegia; Humans; Magnetic Resonance Spectroscopy; Male; Mutation; Sodium-Potassium-Exchanging ATPase; Tritium

2017
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors

2017
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
    Annals of neurology, 2018, Volume: 83, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Aspartic Acid; Ataxins; Brain; Brain Diseases, Metabolic; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Spinocerebellar Ataxias; Young Adult

2018
Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2019, Volume: 163, Issue:1

    Topics: Adult; Aspartic Acid; Atrophy; Disease Progression; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Severity of Illness Index; Thalamus; Young Adult

2019
Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients.
    Psychiatry research. Neuroimaging, 2018, 11-30, Volume: 281

    Topics: Adolescent; Adult; Aspartic Acid; Biomarkers; Case-Control Studies; Choline; Corpus Striatum; Disease Progression; Dopamine; Female; Glutamic Acid; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia; Young Adult

2018
Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Humans; Longitudinal Studies; Male; Middle Aged; Motor Cortex; Motor Neurons; Pons; Prognosis; Proton Magnetic Resonance Spectroscopy; Upper Extremity

2019
Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes.
    Journal of diabetes and its complications, 2019, Volume: 33, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Peripheral Nerves; Polyneuropathies; White Matter

2019
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Journal of neurovirology, 2013, Volume: 19, Issue:3

    Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; Cerebral Cortex; Choline; Cognition; Disease Progression; Female; Glutamic Acid; HIV; Humans; Inositol; Male; Middle Aged; Neuropsychological Tests

2013
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
    Neurology, 2013, Jun-04, Volume: 80, Issue:23

    Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Prodromal Symptoms; Protons; Risk; Syndrome; Young Adult

2013
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Schizophrenia bulletin, 2014, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Aspartic Acid; Chronic Disease; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Risk; Schizophrenia; Young Adult

2014
Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Amyloid; Animals; Apoptosis; Aspartic Acid; Behavior, Animal; Cell Proliferation; Congo Red; Disease Progression; Galactose; Glutamine; Hippocampus; Inositol; Magnetic Resonance Spectroscopy; Male; Maze Learning; Mice; Neurofibrillary Tangles; Neuroglia; Neurons; Sodium Nitrite; Time Factors

2014
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
    Neurological research, 2014, Volume: 36, Issue:8

    Topics: Adult; Aspartic Acid; Cerebral Cortex; Creatine; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Prognosis; Young Adult

2014
Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Brain; Choline; Dementia; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Retrospective Studies; Tritium

2014
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
    JAMA neurology, 2014, Jul-01, Volume: 71, Issue:7

    Topics: Adult; Aspartic Acid; Atrophy; Biomarkers; Case-Control Studies; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Severity of Illness Index

2014
3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
    International journal of radiation oncology, biology, physics, 2014, Sep-01, Volume: 90, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Choline; Contrast Media; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Matched-Pair Analysis; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy Dosage; Temozolomide; Time Factors

2014
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.
    Journal of neurology, 2014, Volume: 261, Issue:12

    Topics: Adult; Aspartic Acid; Axons; Biomarkers; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Neurofilament Proteins; Prognosis

2014
[Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy].
    Rinsho shinkeigaku = Clinical neurology, 2015, Volume: 55, Issue:10

    Topics: Aged; Alzheimer Disease; Amnesia; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Forecasting; Hippocampus; Humans; Male; Proton Magnetic Resonance Spectroscopy

2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Parkinsonism & related disorders, 2016, Volume: 22

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus

2016
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.
    American journal of medical genetics. Part A, 2016, Volume: 170, Issue:3

    Topics: Adolescent; Age of Onset; Aspartic Acid; Atrophy; beta-Galactosidase; Cerebellum; Cerebrum; Child; Child, Preschool; Disease Progression; Female; Gangliosidosis, GM1; Gene Expression; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mobility Limitation; Severity of Illness Index; Speech; Speech Disorders; Young Adult

2016
Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
    Scientific reports, 2016, Feb-23, Volume: 6

    Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Aspartic Acid; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Neurotransmitter Agents; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Regression Analysis; Risk; Severity of Illness Index; Time Factors

2016
Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Journal of neurology, 2016, Volume: 263, Issue:5

    Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aspartic Acid; Brain; Choline; Disability Evaluation; Disease Progression; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Linear Models; Longitudinal Studies; Male; Niemann-Pick Disease, Type C; Patient Dropouts; Treatment Outcome; Young Adult

2016
Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
    Neuroradiology, 2016, Volume: 58, Issue:10

    Topics: Adolescent; Aging; Aspartic Acid; Biomarkers, Tumor; Brain Stem; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Molecular Imaging; Outcome Assessment, Health Care; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden

2016
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    European journal of neurology, 2016, Volume: 23, Issue:12

    Topics: Adult; Aspartic Acid; Axons; Brain; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Retinal Neurons; Sensitivity and Specificity; Tomography, Optical Coherence; White Matter

2016
Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Journal of Huntington's disease, 2016, 10-01, Volume: 5, Issue:3

    Topics: Animals; Aspartic Acid; Brain; Disease Models, Animal; Disease Progression; Glutamic Acid; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Trinucleotide Repeats

2016
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Neurobiology of disease, 2016, Volume: 96

    Topics: Amidohydrolases; Animals; Aspartic Acid; Autophagy-Related Proteins; Basic Helix-Loop-Helix Transcription Factors; Brain; Canavan Disease; Child; Child, Preschool; Dependovirus; Disease Progression; Energy Metabolism; Female; Gene Expression Regulation; Green Fluorescent Proteins; HEK293 Cells; Humans; Infant; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Movement Disorders; Myelin Basic Protein; Myelin Sheath; Neurodegenerative Diseases; Oligodendroglia

2016
Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Radiology, 2017, Volume: 284, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Contrast Media; Diffusion Tensor Imaging; Disease Progression; Female; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Grading; Organometallic Compounds; Prospective Studies; Retrospective Studies

2017
Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Nov-05, Volume: 28, Issue:45

    Topics: Age Factors; Amidohydrolases; Animals; Animals, Newborn; Aspartic Acid; Axons; Behavior, Animal; Canavan Disease; Central Nervous System; Chromosome Mapping; Codon, Nonsense; Disease Models, Animal; Disease Progression; Glutamine; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Sheath; N-Acylsphingosine Galactosyltransferase; Oligodendroglia

2008
Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
    Acta radiologica (Stockholm, Sweden : 1987), 2008, Volume: 49, Issue:10

    Topics: Animals; Aspartic Acid; Brain; Cats; Choline; Contrast Media; Creatine; Disease Models, Animal; Disease Progression; Embolism, Fat; Follow-Up Studies; Gadolinium DTPA; Image Enhancement; Intracranial Embolism; Lactic Acid; Lipid Metabolism; Lipids; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Sodium Chloride; Triolein

2008
Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study.
    Neurology, 2008, Dec-09, Volume: 71, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Brain; Brain Ischemia; Brain Mapping; Cell Death; Diffusion Magnetic Resonance Imaging; Disease Progression; Down-Regulation; Energy Metabolism; Female; Humans; Lactic Acid; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Stroke; Time Factors

2008
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease.
    Journal of neurology, 2008, Volume: 255, Issue:11

    Topics: Aged; alpha-Macroglobulins; Alzheimer Disease; Aspartic Acid; Biomarkers; Complement Factor H; Disease Progression; Electrophoresis, Gel, Two-Dimensional; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Organ Size

2008
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:2

    Topics: Agnosia; Aspartic Acid; Atrophy; Brain; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe

2009
Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, Volume: 11, Issue:1-2

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Diffusion Tensor Imaging; Disease Progression; Female; Humans; Internal Capsule; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Pyramidal Tracts; ROC Curve; Sensitivity and Specificity

2010
Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Neuropediatrics, 2008, Volume: 39, Issue:5

    Topics: Aspartic Acid; Basal Ganglia; Brain; Cerebral Cortex; Child, Preschool; Choline; Corpus Callosum; Creatine; Disease Progression; Diseases in Twins; DNA Mutational Analysis; Dominance, Cerebral; Energy Metabolism; Epilepsies, Myoclonic; Female; Gangliosidoses, GM2; Hexosaminidase A; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nerve Fibers, Myelinated; Neurologic Examination; Thalamus; Twins, Monozygotic

2008
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Neurology, 2009, Apr-14, Volume: 72, Issue:15

    Topics: Amino Acids; Aspartic Acid; Axons; Biomarkers; Cohort Studies; Disease Progression; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Nerve Degeneration; Neurofilament Proteins; tau Proteins

2009
Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.
    Neurology, 2009, Apr-28, Volume: 72, Issue:17

    Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Biomarkers; Brain; CD4-CD8 Ratio; Disease Progression; Early Diagnosis; Frontal Lobe; Glutamic Acid; HIV Seropositivity; Humans; Immunophenotyping; Magnetic Resonance Spectroscopy; Middle Aged; Neurons; T-Lymphocytes

2009
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Neurology, 2009, Apr-28, Volume: 72, Issue:17

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Atrophy; Biomarkers; Brain; Cerebrovascular Disorders; Cognition Disorders; Cohort Studies; Creatine; Dementia; Disease Progression; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors

2009
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Psychiatry research, 2009, Jul-15, Volume: 173, Issue:1

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Follow-Up Studies; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Parietal Lobe; Prognosis; Severity of Illness Index

2009
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:7

    Topics: Adult; Aspartic Acid; Axons; Biomarkers; Brain; Brain Chemistry; Cell Survival; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Severity of Illness Index; Young Adult

2009
A proton magnetic resonance spectroscopic study in juvenile absence epilepsy in early stages.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2010, Volume: 14, Issue:3

    Topics: Adolescent; Aspartic Acid; Brain; Child; Choline; Creatine; Disease Progression; Down-Regulation; Electroencephalography; Epilepsy, Absence; Female; Frontal Lobe; Functional Laterality; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Membrane Potentials; Neurotoxins; Predictive Value of Tests; Thalamus

2010
Prolonged neurologic course of familial hemophagocytic lymphohistiocytosis.
    Pediatric neurology, 2009, Volume: 41, Issue:3

    Topics: Aspartic Acid; Bone Marrow; Brain; Child; Choline; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Ferritins; Fibrinogen; Humans; Lactic Acid; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Remission Induction; Siblings; Triglycerides

2009
In vivo glutamate decline associated with kainic acid-induced status epilepticus.
    Brain research, 2009, Dec-01, Volume: 1300

    Topics: Analysis of Variance; Animals; Aspartic Acid; Disease Progression; Glutamic Acid; Hippocampus; Image Processing, Computer-Assisted; Immunohistochemistry; Kainic Acid; Lactic Acid; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurons; Organ Size; Rats; Rats, Wistar; Seizures; Status Epilepticus; Time Factors

2009
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Neuroradiology, 2010, Volume: 52, Issue:4

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Perfusion Imaging; Pilot Projects; Retrospective Studies

2010
Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology.
    Journal of neurotrauma, 2010, Volume: 27, Issue:3

    Topics: Animals; Aspartic Acid; Choline; Creatine; Disease Models, Animal; Disease Progression; Gliosis; Immunohistochemistry; Magnetic Resonance Spectroscopy; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Time Factors; Wallerian Degeneration

2010
Spinal cord repair in MS: does mitochondrial metabolism play a role?
    Neurology, 2010, Mar-02, Volume: 74, Issue:9

    Topics: Adult; Aspartic Acid; Axons; Cervical Vertebrae; Disease Progression; Female; Follow-Up Studies; Humans; Linear Models; Logistic Models; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Mitochondria; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Nerve Degeneration; Organ Size; Reactive Oxygen Species; Spinal Cord; Time Factors

2010
The brake on neurodegeneration: Increased mitochondrial metabolism in the injured MS spinal cord.
    Neurology, 2010, Mar-02, Volume: 74, Issue:9

    Topics: Aspartic Acid; Cervical Vertebrae; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mitochondria; Multiple Sclerosis; Nerve Degeneration; Organ Size; Reactive Oxygen Species; Spinal Cord; Time Factors

2010
Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients.
    Journal of psychiatric research, 2011, Volume: 45, Issue:4

    Topics: Adult; Age of Onset; Aspartic Acid; Choline; Chronic Disease; Depressive Disorder, Major; Disease Progression; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Prefrontal Cortex

2011
Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).
    Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3

    Topics: Adolescent; Aspartic Acid; Basal Ganglia; Biomarkers; Brain; Case-Control Studies; Child; Child, Preschool; Choline; Disease Progression; Enzyme Replacement Therapy; Glutamic Acid; Humans; Iduronate Sulfatase; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mucopolysaccharidosis II; Predictive Value of Tests; Treatment Outcome

2010
Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.
    Journal of neurology, 2011, Volume: 258, Issue:5

    Topics: Adult; Aspartic Acid; Cognition Disorders; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Neurons; Neuropsychological Tests; Young Adult

2011
Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.
    Neuroradiology, 2011, Volume: 53, Issue:12

    Topics: Aged; Aspartic Acid; Biomarkers; Brain; Choline; Creatine; Creutzfeldt-Jakob Syndrome; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution

2011
Temporal evolution of sporadic Creutzfeldt-Jakob disease monitored by 3-Tesla MR spectroscopy.
    Journal of neurology, 2011, Volume: 258, Issue:7

    Topics: Aged; Aspartic Acid; Choline; Creutzfeldt-Jakob Syndrome; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male

2011
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:12

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Temporal Lobe

2011
Subependymal seeding of low-grade oligodendroglial neoplasms: a case series.
    Journal of neuro-oncology, 2012, Volume: 108, Issue:1

    Topics: Adult; Aspartic Acid; Creatine; Disease Progression; Ependyma; Fourth Ventricle; Glioma; Humans; Isocitrate Dehydrogenase; Ki-67 Antigen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mutation; Neoplasm Seeding; Retrospective Studies; Supratentorial Neoplasms; Young Adult

2012
Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin-induced diabetes detected using in vivo ¹H MR spectroscopy at 9.4 T.
    Journal of neurochemistry, 2012, Volume: 121, Issue:3

    Topics: Acute Disease; Algorithms; Animals; Aspartic Acid; Biological Transport, Active; Blood Glucose; Blood-Brain Barrier; Brain Chemistry; Cerebral Cortex; Chronic Disease; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Progression; Glucose; Glutathione; Hippocampus; Hyperglycemia; Kinetics; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Sprague-Dawley

2012
Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
    Dementia and geriatric cognitive disorders, 2012, Volume: 33, Issue:2-3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognition Disorders; Creatine; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Intelligence Tests; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Statistics as Topic

2012
A 9-year follow-up of a girl with pyridoxine (vitamin B6)-dependent seizures: magnetic resonance spectroscopy findings.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:5

    Topics: Adolescent; Anticonvulsants; Aspartic Acid; Biomarkers; Brain; Child; Creatinine; Disease Progression; Epilepsy; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Predictive Value of Tests; Pyridoxine; Treatment Outcome; Vitamin B Complex

2012
Relationship between enzyme properties and disease progression in Canavan disease.
    Journal of inherited metabolic disease, 2013, Volume: 36, Issue:1

    Topics: Amidohydrolases; Aspartic Acid; Brain; Canavan Disease; Catalysis; Disease Progression; Humans; Mutation; Phenotype

2013
Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Adult; Age of Onset; Aged; Aspartic Acid; Case-Control Studies; Cerebellum; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Tissue Proteins; Research Design; Retrospective Studies; Severity of Illness Index; Spinocerebellar Ataxias; Taiwan; Trinucleotide Repeats

2012
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6

    Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed

2012
The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 12

    Topics: Acoustic Stimulation; Age Factors; Aging, Premature; Animals; Aspartic Acid; Chi-Square Distribution; Creatine; Disease Models, Animal; Disease Progression; Electron Transport Chain Complex Proteins; Electron Transport Complex IV; Electroretinography; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Gene Expression Regulation; Glycolysis; GTP Phosphohydrolases; Humans; Lactic Acid; Locomotion; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Diseases; Muscle, Skeletal; Nervous System; Optic Atrophy, Autosomal Dominant; Optic Nerve; Phenotype; Physical Conditioning, Animal; Psychoacoustics; Psychomotor Performance; Reaction Time; Retina; Retinal Ganglion Cells; Sequence Deletion

2012
Novel hypomyelinating leukoencephalopathy affecting early myelinating structures: clinical course in two brothers.
    Neuropediatrics, 2013, Volume: 44, Issue:4

    Topics: Aspartic Acid; Cerebellum; Child; Child, Preschool; Disease Progression; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nerve Fibers, Myelinated; Siblings

2013
Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
    Journal of neurology, 2002, Volume: 249, Issue:7

    Topics: Adult; Aspartic Acid; Atrophy; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Occipital Lobe; Parietal Lobe; Recurrence; Water

2002
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.
    Brain : a journal of neurology, 2003, Volume: 126, Issue:Pt 2

    Topics: Adult; Aspartic Acid; Axons; Brain; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Time Factors

2003
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
    Experimental neurology, 2003, Volume: 179, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain; Cats; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Disease Progression; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurologic Examination; Pargyline; Parkinsonian Disorders; Predictive Value of Tests; Protons; Tyrosine 3-Monooxygenase

2003
Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.
    Journal of neurology, 2003, Volume: 250, Issue:3

    Topics: Alexander Disease; Aspartic Acid; Brain; Child; Child, Preschool; Demyelinating Diseases; Disease Progression; Female; Gliosis; Humans; Infant; Inositol; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nerve Degeneration; Radiography

2003
Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes?
    Neurology, 2003, Apr-22, Volume: 60, Issue:8

    Topics: Adult; Aspartic Acid; Atrophy; Brain Stem; Choline; Creatinine; Disease Progression; Evoked Potentials, Motor; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neuron Disease; Muscle Spasticity; Neurons; Psychomotor Performance; Reflex, Abnormal; Reflex, Startle

2003
Whole-brain N-acetylaspartate level and cognitive performance in HIV infection.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:8

    Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Atrophy; Brain; Disease Progression; Energy Metabolism; Female; HIV Seropositivity; HIV-1; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurons; Neuropsychological Tests; Reference Values; Sensitivity and Specificity

2003
Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:8

    Topics: Adolescent; Aspartic Acid; Brain; Cerebellar Nuclei; Choline; Creatine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Disease Progression; Energy Metabolism; Follow-Up Studies; Globus Pallidus; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurologic Examination; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Reference Values; Thalamus

2003
Neuronal damage after ischemic injury in the middle cerebral arterial territory: deep watershed versus territorial infarction at MR perfusion and spectroscopic imaging.
    Radiology, 2003, Volume: 229, Issue:2

    Topics: Aspartic Acid; Blood Volume; Brain; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Contrast Media; Diagnosis, Differential; Disease Progression; Female; Humans; Infarction, Middle Cerebral Artery; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurons; Time Factors

2003
Reduced N-acetylaspartate levels and cognitive decline.
    Archives of neurology, 2004, Volume: 61, Issue:2

    Topics: Alleles; Apolipoproteins E; Aspartic Acid; Brain Chemistry; Cognition Disorders; Disease Progression; Humans; Multiple Sclerosis

2004
Neuronal cell injury precedes brain atrophy in multiple sclerosis.
    Neurology, 2004, Feb-24, Volume: 62, Issue:4

    Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Chemistry; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurons; Severity of Illness Index; Time Factors

2004
Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
    Cancer, 2004, Mar-15, Volume: 100, Issue:6

    Topics: Adolescent; Aspartic Acid; Brain Chemistry; Brain Neoplasms; Child; Child, Preschool; Choline; Disease Progression; Female; Humans; Infant; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Prognosis

2004
A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
    BMC neuroscience, 2004, Mar-05, Volume: 5

    Topics: Acute Disease; AIDS Dementia Complex; Animals; Aspartic Acid; Brain; Choline; Chronic Disease; Creatine; Disease Models, Animal; Disease Progression; Female; Inositol; Longitudinal Studies; Macaca mulatta; Magnetic Resonance Spectroscopy; Male; Predictive Value of Tests; Prospective Studies; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Survival Rate; Viral Load

2004
Leukoencephalopathy, cerebral calcifications, and cysts: new observations.
    Neurology, 2004, Apr-13, Volume: 62, Issue:7

    Topics: Adolescent; Aspartic Acid; Brain; Brain Diseases; Calcinosis; Central Nervous System Cysts; Child; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Rare Diseases; Retinal Diseases; Syndrome; Tomography, X-Ray Computed

2004
MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
    AJNR. American journal of neuroradiology, 2004, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Cerebral Ventricles; Child; Child, Preschool; Choline; Creatine; Disease Progression; Energy Metabolism; Female; Humans; Image Processing, Computer-Assisted; Infant; Inositol; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myelin Sheath; Nerve Fibers, Myelinated; Neurologic Examination; Sjogren-Larsson Syndrome

2004
Subacute sclerosing panencephalitis with fulminating course: follow-up magnetic resonance spectroscopy (MRS) findings.
    Journal of child neurology, 2004, Volume: 19, Issue:3

    Topics: Aspartic Acid; Brain; Cerebral Cortex; Child, Preschool; Choline; Creatine; Diagnosis, Differential; Disease Progression; Dominance, Cerebral; Energy Metabolism; Female; Follow-Up Studies; Gliosis; Humans; Image Enhancement; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Myelin Sheath; Neurologic Examination; Neurons; Subacute Sclerosing Panencephalitis

2004
Five new cases of a recently described leukoencephalopathy with high brain lactate.
    Neurology, 2004, Aug-24, Volume: 63, Issue:4

    Topics: Adolescent; Aspartic Acid; Ataxia; Brain Chemistry; Brain Diseases, Metabolic; Brain Stem; Central Nervous System Diseases; Child; Child, Preschool; Choline; Disease Progression; Evoked Potentials, Somatosensory; Female; Finland; Genes, Recessive; Humans; Lactates; Magnetic Resonance Imaging; Male; Muscle Spasticity; Pedigree; Sensation Disorders; Spinal Cord; Tremor

2004
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Journal of neurosurgery, 2004, Volume: 101, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Creatine; Disease Progression; Energy Metabolism; Female; Glioblastoma; Humans; Image Processing, Computer-Assisted; Lactic Acid; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuronavigation; Prognosis; Radiosurgery; Reoperation; Risk; Survival Analysis

2004
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
    Neurology, 2004, Sep-14, Volume: 63, Issue:5

    Topics: Adult; Aspartic Acid; Cerebellum; Cerebral Cortex; Choline; Creatine; Disease Progression; Female; HIV Infections; Humans; Inositol; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Survivors; T-Cell Antigen Receptor Specificity; T-Lymphocytes, Cytotoxic

2004
Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.
    Neurobiology of disease, 2005, Volume: 18, Issue:1

    Topics: Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Aspartic Acid; Biomarkers; Disease Models, Animal; Disease Progression; Energy Metabolism; Female; Frontal Lobe; Glutamic Acid; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Presenilin-2; Spectrum Analysis

2005
Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury.
    Journal of neurotrauma, 2004, Volume: 21, Issue:11

    Topics: Adolescent; Age Factors; Aspartic Acid; Brain; Brain Injuries; Child; Child, Preschool; Choline; Coma; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Nerve Degeneration; Occipital Lobe; Parietal Lobe; Predictive Value of Tests; Recovery of Function; Up-Regulation

2004
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Journal of neuro-oncology, 2005, Volume: 71, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous System Neoplasms; Choline; Creatine; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Immunocompetence; Lactic Acid; Lipid Metabolism; Lymphoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Protons; Survival Analysis

2005
Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients.
    Neurology, 2005, Feb-08, Volume: 64, Issue:3

    Topics: Adolescent; Adrenoleukodystrophy; Aspartic Acid; Brain Chemistry; Child; Child, Preschool; Creatine; Disease Progression; Follow-Up Studies; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Inositol; Lactates; Lipids; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Prognosis

2005
Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Archives of neurology, 2005, Volume: 62, Issue:4

    Topics: Adult; Aspartic Acid; Astrocytes; Atrophy; CD3 Complex; Cell Communication; Cells, Cultured; Central Nervous System; Coculture Techniques; Cohort Studies; Disease Progression; Endothelial Cells; Female; Humans; Interferon-beta; Magnetic Resonance Spectroscopy; Male; Microglia; Multiple Sclerosis; Nerve Growth Factor; T-Lymphocytes; Wallerian Degeneration

2005
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    International journal of radiation oncology, biology, physics, 2005, May-01, Volume: 62, Issue:1

    Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression; Feasibility Studies; Female; Glioma; Humans; Lactic Acid; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neoplasm Recurrence, Local; Pons

2005
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Neurobiology of aging, 2006, Volume: 27, Issue:7

    Topics: Aged; Amnesia; Aspartic Acid; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Functional Laterality; Humans; Inositol; Lateral Ventricles; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Nerve Fibers, Myelinated; Predictive Value of Tests; Protons

2006
Diffuse structural and metabolic brain changes in Fabry disease.
    Journal of neurology, 2006, Volume: 253, Issue:4

    Topics: Adult; alpha-Galactosidase; Aspartic Acid; Axons; Brain; Brain Chemistry; Disease Progression; DNA; Fabry Disease; Female; Heterozygote; Homozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mutation

2006
Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.
    Journal of child neurology, 2006, Volume: 21, Issue:2

    Topics: Adolescent; Antiviral Agents; Artifacts; Aspartic Acid; Choline; Disease Progression; Dominance, Cerebral; Female; Frontal Lobe; gamma-Aminobutyric Acid; Humans; Inosine Pranobex; Inositol; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurologic Examination; Reproducibility of Results; Subacute Sclerosing Panencephalitis

2006
[Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2006, Volume: 178, Issue:6

    Topics: Adult; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Chemotherapy, Adjuvant; Choline; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oligodendroglioma; Phosphocreatine; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Reference Values; Stereotaxic Techniques

2006
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
    Neurobiology of aging, 2007, Volume: 28, Issue:9

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Choline; Cognition Disorders; Creatine; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Retrospective Studies

2007
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    The European journal of neuroscience, 2007, Volume: 25, Issue:6

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Aspartic Acid; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Mutation; Nerve Degeneration; Superoxide Dismutase; Time Factors

2007
Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
    Neurology, 2007, Apr-24, Volume: 68, Issue:17

    Topics: Aspartic Acid; Brain Chemistry; Confounding Factors, Epidemiologic; Disease Progression; Humans; Inosine Pranobex; Inositol; Magnetic Resonance Spectroscopy; Neurons; Subacute Sclerosing Panencephalitis

2007
MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
    Neurobiology of disease, 2007, Volume: 26, Issue:3

    Topics: Animals; Aspartic Acid; Astrocytes; Body Water; Brain; Choline; Creatine; Diffusion; Disease Models, Animal; Disease Progression; Gliosis; Glucose; Glutamic Acid; Hyperkinesis; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Microglia; Prion Diseases

2007
Time course of early metabolic changes following diffuse traumatic brain injury in rats as detected by (1)H NMR spectroscopy.
    Journal of neurotrauma, 2007, Volume: 24, Issue:6

    Topics: Amino Acids; Animals; Aspartic Acid; Brain; Brain Chemistry; Brain Injuries; Creatine; Diffuse Axonal Injury; Disease Models, Animal; Disease Progression; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Time Factors; Up-Regulation; Water-Electrolyte Balance

2007
Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Neurology, 2007, Jul-03, Volume: 69, Issue:1

    Topics: Adult; Aspartic Acid; Axons; Brain; Brain Chemistry; Choline; Creatine; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Severity of Illness Index

2007
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
    Neurology, 2007, Aug-07, Volume: 69, Issue:6

    Topics: Adolescent; Age Factors; Age of Onset; Aminopeptidases; Aspartic Acid; Cerebral Cortex; Child; Child, Preschool; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Progression; DNA Mutational Analysis; Endopeptidases; Female; Humans; Magnetic Resonance Imaging; Male; Mutation, Missense; Neurologic Examination; Neuronal Ceroid-Lipofuscinoses; Nuclear Magnetic Resonance, Biomolecular; Ophthalmoscopy; Organ Size; Point Mutation; Retina; Serine Proteases; Severity of Illness Index; Siblings; Tripeptidyl-Peptidase 1

2007
Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    European neurology, 2007, Volume: 58, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease Progression; Female; Glioma; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Retrospective Studies

2007
Early and sustained alterations in cerebral metabolism after traumatic brain injury in immature rats.
    Journal of neurotrauma, 2008, Volume: 25, Issue:6

    Topics: Aging; Alanine; Animals; Animals, Newborn; Aspartic Acid; Brain; Brain Injuries; Cell Respiration; Choline; Creatine; Disease Progression; Energy Metabolism; Glycolysis; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Mitochondria; Nerve Degeneration; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors

2008
Imaging of axonal damage in vivo in Rasmussen's syndrome.
    Brain : a journal of neurology, 1995, Volume: 118 ( Pt 3)

    Topics: Adolescent; Aspartic Acid; Brain Chemistry; Child; Chronic Disease; Creatine; Disease Progression; Encephalitis; Epilepsies, Partial; Female; Hemiplegia; Humans; Magnetic Resonance Imaging; Male; Status Epilepticus; Syndrome

1995
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    NMR in biomedicine, 1996, Volume: 9, Issue:8

    Topics: Aspartic Acid; Brain; Creatine; Disease Progression; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Theoretical; Multiple Sclerosis; Recurrence; Reference Values

1996
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed

1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Progression; Feasibility Studies; Follow-Up Studies; Glioblastoma; Humans; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Protons; Radiation Injuries; Radiography, Interventional; Retrospective Studies; Stereotaxic Techniques; Supratentorial Neoplasms; Tomography, X-Ray Computed

1997
Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:2

    Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Disease Progression; Female; Follow-Up Studies; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination

1998
Proton magnetic resonance spectroscopy of linear nevus sebaceus syndrome.
    Pediatric neurology, 1998, Volume: 18, Issue:2

    Topics: Aspartic Acid; Brain Chemistry; Cerebral Cortex; Child, Preschool; Choline; Creatine; Disease Progression; Hamartoma; Humans; Infant; Inositol; Magnetic Resonance Spectroscopy; Male; Skin Neoplasms; Syndrome

1998
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    Brain : a journal of neurology, 1998, Volume: 121 ( Pt 8)

    Topics: Aspartic Acid; Axons; Brain; Creatine; Disability Evaluation; Disease Progression; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Recurrence

1998
Prediction of cognitive decline in early Alzheimer's disease.
    Lancet (London, England), 1998, Nov-21, Volume: 352, Issue:9141

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain Chemistry; Cognition; Disease Progression; Humans; Magnetic Resonance Spectroscopy; Predictive Value of Tests; Prognosis; Reproducibility of Results

1998
Proton magnetic resonance spectroscopy (1H MRS) in patients with sporadic cerebellar degeneration.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1999, Volume: 9, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Atrophy; Cerebellar Diseases; Cerebellum; Choline; Creatine; Disease Progression; Female; Frontal Lobe; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Phosphocreatine; Protons; Putamen

1999
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Italian journal of neurological sciences, 1999, Volume: 20, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Phosphocreatine; Supranuclear Palsy, Progressive

1999
Total brain N-acetylaspartate: a new measure of disease load in MS.
    Neurology, 2000, Jan-11, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aspartic Acid; Biomarkers; Brain; Cell Survival; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Neurons; Reference Values; Reproducibility of Results; Severity of Illness Index

2000
MR spectroscopy in gliomatosis cerebri.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Child; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasms, Neuroepithelial; Prognosis; Stereotaxic Techniques

2000
Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
    NMR in biomedicine, 2000, Volume: 13, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Phosphocreatine

2000
Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.
    Lancet (London, England), 2000, May-13, Volume: 355, Issue:9216

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurons; Prospective Studies; Sensitivity and Specificity

2000
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Neurology, 2000, Jul-25, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain Mapping; Choline; Cognition Disorders; Creatine; Disease Progression; Energy Metabolism; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Occipital Lobe; Reference Values; Temporal Lobe

2000
Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis.
    Acta neurologica Scandinavica, 2000, Volume: 102, Issue:3

    Topics: Adult; Age Factors; Aspartic Acid; Case-Control Studies; Child; Child, Preschool; Creatine; Disease Progression; Epilepsy; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Tomography, Emission-Computed, Single-Photon; Tuberous Sclerosis

2000
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    Archives of neurology, 2001, Volume: 58, Issue:1

    Topics: Adult; Aspartic Acid; Atrophy; Axons; Brain; Chromatography, High Pressure Liquid; Creatine; Disability Evaluation; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Severity of Illness Index; Spinal Cord; Time Factors

2001
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Archives of neurology, 2001, Volume: 58, Issue:5

    Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Phosphocreatine; Reference Values; Severity of Illness Index

2001
Correlation of cerebral metabolites with clinical outcome among patients with severe congestive heart failure.
    Circulation, 2001, Jun-12, Volume: 103, Issue:23

    Topics: Aspartic Acid; Brain; Choline; Cognition Disorders; Creatine; Disease Progression; Heart Failure; Humans; Inositol; Magnetic Resonance Spectroscopy; Neurons; Predictive Value of Tests

2001
Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study.
    Journal of neurology, 2001, Volume: 248, Issue:5

    Topics: Adolescent; Adult; Aspartic Acid; Creatine; Cysts; Dementia, Vascular; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Phosphocreatine

2001
Editorial commentary to Narayanan et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.
    Journal of neurology, 2001, Volume: 248, Issue:11

    Topics: Adjuvants, Immunologic; Aspartic Acid; Clinical Trials as Topic; Diffuse Axonal Injury; Disease Progression; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Reproducibility of Results; Research Design; Treatment Outcome

2001
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Neurology, 2002, Mar-12, Volume: 58, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Reproducibility of Results

2002